Human Longevity Stock

www.humanlongevity.comHealthcareFounded: 2013Funding to Date: $49.3MM

Human Longevity is a genomics-based, health intelligence company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data.

Register for Details

For more details on financing and valuation for Human Longevity, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Human Longevity.

Register Today

Human Longevity investors also invested in these private companies

Team

Management Team

Felix Frueh
Chief Scientific Officer
Yaron Turpaz
Chief Information Officer
Williams Biggs
Head, Genomic Sequencing
J. Venter
Co-founder and CEO

Board Members

David Brenner
University of California, San Diego
James Brewer
University of California, San Diego
Delos Cosgrove
Cleveland Clinic
Eric Anderson
Intentional Software

Other companies like Human Longevity in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$885.01MM

News

The genome sequencing company plans to go public through a merger with Freedom Acquisition I Corp that values the combined company at about $1B.
The genetic testing company NeoGenomics has acquired Human Longevity’s oncology division, which provides next-generation sequencing services. The division
Dr. Nir Barzilai, a Milken Institute Center for the Future on Aging Longevity Innovator, discusses his latest research and what's ahead.